SENORES
Invest with MTF
Invest Now
Invest in Senores Pharmaceuticals with 3.01X leverage
Performance
- Low
- ₹795
- High
- ₹836
- 52 Week Low
- ₹440
- 52 Week High
- ₹877
- Open Price₹836
- Previous Close₹838
- Volume200,814
- 50 DMA₹800.92
- 100 DMA₹765.24
- 200 DMA₹692.96
Investment Returns
- Over 1 Month -0.31%
- Over 3 Month + 7.6%
- Over 6 Month + 31.7%
- Over 1 Year + 47.93%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 36.4
- PEG Ratio
- 0.6
- Market Cap Cr
- 3,694
- P/B Ratio
- 4.5
- Average True Range
- 36.67
- EPS
- 22.06
- Dividend Yield
- 0
- MACD Signal
- 4.22
- RSI
- 47.45
- MFI
- 41.35
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
Current Price
₹802.00
-36.15
(-4.31%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹815.22
- 50 Day
- ₹800.92
- 100 Day
- ₹765.24
- 200 Day
- ₹692.96
Resistance and Support
810.95
- R3 868.20
- R2 852.10
- R1 827.05
- S1 785.90
- S2 769.80
- S3 744.75
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-20 | Quarterly Results & Others | To consider other business matters. |
| 2026-01-07 | Others | Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group. |
| 2025-11-06 | Quarterly Results | |
| 2025-07-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-15 | Audited Results |
Senores Pharmaceuticals F&O
About Senores Pharmaceuticals
- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- Managing Director
- Mr. Swapnil Jatinbhai Shah
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹802 As on 24 January, 2026 | 16:48
The Market Cap of Senores Pharmaceuticals is ₹3693.5 Cr As on 24 January, 2026 | 16:48
The P/E ratio of Senores Pharmaceuticals is 36.4 As on 24 January, 2026 | 16:48
The PB ratio of Senores Pharmaceuticals is 4.5 As on 24 January, 2026 | 16:48
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.